Tiwari, Bishal. “FDA Approved Durvalumab for Limited-Stage Small Cell Lung Cancer”. Nepalese Journal of Cancer 9, no. 1 (April 1, 2025): 9–14. Accessed December 6, 2025. https://nepjol.info/index.php/njc/article/view/77006.